Zobrazeno 1 - 2
of 2
pro vyhledávání: '"S de la Fuente Ruiz"'
Autor:
M Cárdenas Aranzana, S de la Fuente Ruiz, D Ruiz Vílchez, R. Ortega Castro, J Calvo Guitiérrez, M Romero Gomez, P Font Ugalde, M. D. C. Castro Villegas, E Colllantes Estévez
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: Dose optimisation (dose reduction or dose spacing) is a therapeutic strategy applied in patients with rheumatoid arthritis (RA) who have managed to maintain clinical remission. This strategy reduces the frequency of adverse effects and pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff30816e02788203965ed2010f5f8e48
https://doi.org/10.1136/ejhpharm-2018-eahpconf.242
https://doi.org/10.1136/ejhpharm-2018-eahpconf.242
Autor:
MC Garzas-Martin, T Brieva Herrera, S de la Fuente Ruiz, N Garcia Melero, de Almagro, B Galvez Criado
Publikováno v:
European Journal of Hospital Pharmacy. 20:A105.1-A105
Background Clofarabine is a purine nucleoside antimetabolite, a second-generation antineoplastic indicated for the treatment of acute lymphoblastic leukaemia in paediatric patients (≤ 21 years) who have relapsed or are refractory after receiving at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd2dd57b0174707917fc8c7028fb3383
https://doi.org/10.1136/ejhpharm-2013-000276.293
https://doi.org/10.1136/ejhpharm-2013-000276.293